Recent advances in biotechnology, cloning and genetics have made possible a wide
range of new technologies and products. Over the next decade these may revolutionise
both commercial livestock production and the companion animal sector. This Animal
Pharm report is the first to identify the commercial potential of these new technologies.
Key features of the report
An analysis of advances in four key industry sectors:
transgenic animals, cloning and genomic sequencing
therapies using bacteriophages, monoclonal antibodies, stem cells and therapeutic
proteins
vaccines, including plant-based and DNA vaccines
diagnostics, including tests for BSE, trace back of food and inherited diseases
Each of these sections identifies the leading companies and their technologies;
the commercial potential of the developments; and the technical and commercial
constraints that must be overcome
A review of the structure of the animal biotechnology industry, identifying the
key players and the partnerships that have developed between the major animal
health multinationals and the R&D-focused start-ups
67 profiles of the leading academic and government research institutions and
commercial companies at the cutting edge of animal biotechnology R&D, allowing
you to identify potential R&D partners, or your competitors in developing
the technologies of the future
An easy-to-understand introduction to the technical background to the new industry
and a glossary of key terms, making this report accessible to specialists and
non-specialists alike
An analysis of the key issues in terms of regulations and public acceptance,
allowing you to judge the commercial potential of new technologies and products
More than 150 academic and business references, allowing you to further investigate
the key research that has been identified.
1 Biotechnology: introduction and definitions
2 The market and industry in context
3 Transgenic animals and cloning
4 Therapies of the future
5 Vaccines of the future
6 Diagnostics of the future
7 Companies, academia and government institutions
This report covers the new opportunities in animal health created by biotechnology,
including transgenic animals and cloning, genome sequencing, genetic testing,
recombinant proteins and vaccines. The science is put in the context of commercial
opportunities for applications of scientific breakthroughs to develop new products
for animal health.
In order to understand the technology and its commercial potential, the history
of biotech products for animal health is reviewed, including background on the
drugs and vaccines that have been approved worldwide. The regulatory issues raised
by these new technologies, and how the regulators are approaching transgenic and
cloned animals and their products is reviewed, with the latest information through
the end of 2003.
